Dr.Ganesan'S Hitech Diagnostic Centre Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 30-04-2024
- Paid Up Capital ₹ 3.22 Cr
as on 30-04-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 3.00 Cr
as on 30-04-2024
- Revenue 51.25%
(FY 2021)
- Profit 172.65%
(FY 2021)
- Ebitda 119.69%
(FY 2021)
- Net Worth -9.86%
(FY 2021)
- Total Assets 32.08%
(FY 2021)
About Dr.Ganesan'S Hitech Diagnostic Centre
- CIN/LLPIN
U93000TN2009PTC070768
- Company No.
070768
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2009
- Date of AGM
22 Oct 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dr.Ganesan'S Hitech Diagnostic Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramanian Ganesan  | Managing Director | 18-Feb-2009 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alangadan Kannan | Director | 22-Oct-2021 | Current |
| Ameera Shah | Director | 09-Nov-2021 | Current |
| Rakesh Agarwal | Director | 22-Oct-2021 | Current |
Financial Performance of Dr.Ganesan'S Hitech Diagnostic Centre.
Dr.Ganesan'S Hitech Diagnostic Centre Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 51.25% increase. The company also saw a substantial improvement in profitability, with a 172.65% increase in profit. The company's net worth dipped by a decrease of 9.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Ganesan'S Hitech Diagnostic Centre?
In 2021, Dr.Ganesan'S Hitech Diagnostic Centre had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Centre For Digestive And Kidney Diseases (India) Private LimitedActive 20 years 7 monthsRakesh Agarwal is a mutual person
Centralab Healthcare Services Private LimitedActive 13 years 8 monthsAmeera Shah, Rakesh Agarwal and 1 more are mutual person
- Metropolis Health Products Retail Private LimitedActive 11 years 9 months
Ameera Shah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 27 Nov 2015 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Dr.Ganesan'S Hitech Diagnostic Centre?
Dr.Ganesan'S Hitech Diagnostic Centre has a workforce of 692 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Ganesan'S Hitech Diagnostic Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Ganesan'S Hitech Diagnostic Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
